Foresite Capital Management VI LLC Diversified Active

Name: Foresite Capital Management VI LLC Q4 2024 13F Filing | 13F Explorer
Creator: Foresite Capital Management VI LLC
Published: 2025-02-14

Location: West Hollywood, CA

CIK: 0002013341 · Show all filings

Period: Q4 2024 (Next →)

Filing Date: Feb 14, 2025

Total Value: $224M (100.0% shares, 0.0% debt)

Holdings (14)

CGON CG Oncology, Inc. 28.4%

Value $63.71M Shares 2,221,474 Est. Cost $34.21 Unrealized 0.0%

ALMS Alumis Inc 14.7%

Value $33.03M Shares 4,202,670 Est. Cost $10.02 Unrealized 0.0%

CNTA Centessa Pharmaceuticals Inc 9.4%

Value $20.99M Shares 1,253,379 Est. Cost $16.75 Unrealized —

— Rapt Therapeutics Inc 8.8%

Value $19.75M Shares 12,500,000 Est. Cost $1.58 Unrealized —

BCAX Bicara Therapeutics Inc 7.4%

Value $16.55M Shares 950,000 Est. Cost $20.81 Unrealized 0.0%

EWTX Edgewise Therapeutics Inc 7.0%

Value $15.62M Shares 585,000 Est. Cost $31.84 Unrealized 0.0%

GPCR Structure Therapeutics Inc 5.1%

Value $11.39M Shares 420,000 Est. Cost $27.12 Unrealized —

— Akero Therapeutics Inc 4.5%

Value $10.15M Shares 365,000 Est. Cost $27.82 Unrealized —

CRVS Corvus Pharmaceuticals Inc 3.8%

Value $8.46M Shares 1,581,233 Est. Cost $7.47 Unrealized 0.0%

CGEM Cullinan Therapeutics Inc 3.4%

Value $7.729M Shares 634,558 Est. Cost $14.37 Unrealized 0.0%

ALLO Allogene Therapeutics Inc 3.3%

Value $7.345M Shares 3,448,275 Est. Cost $2.47 Unrealized 0.0%

KYMR Kymera Therapeutics Inc 2.6%

Value $5.887M Shares 146,332 Est. Cost $45.17 Unrealized 0.0%

CASIF Casi Pharmaceuticals Inc 1.7%

Value $3.762M Shares 1,329,383 Est. Cost $4.74 Unrealized 0.0%

VRDN Viridian Therapeutics, Inc 0.0%

Value $37,842 Shares 1,974 Est. Cost $21.74 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG Oncology, Inc.	2,221,474	$63.71M	28.4%	$34.21	0.0%	COM	156944100
ALMS	Alumis Inc	4,202,670	$33.03M	14.7%	$10.02	0.0%	COM	022307102
CNTA	Centessa Pharmaceuticals Inc	1,253,379	$20.99M	9.4%	$16.75	—	SPONSORED ADS	152309100
—	Rapt Therapeutics Inc	12,500,000	$19.75M	8.8%	$1.58	—	COM	75382E109
BCAX	Bicara Therapeutics Inc	950,000	$16.55M	7.4%	$20.81	0.0%	COM	055477103
EWTX	Edgewise Therapeutics Inc	585,000	$15.62M	7.0%	$31.84	0.0%	COM	28036F105
GPCR	Structure Therapeutics Inc	420,000	$11.39M	5.1%	$27.12	—	SPONSORED ADS	86366E106
—	Akero Therapeutics Inc	365,000	$10.15M	4.5%	$27.82	—	COM	00973Y108
CRVS	Corvus Pharmaceuticals Inc	1,581,233	$8.46M	3.8%	$7.47	0.0%	COM	221015100
CGEM	Cullinan Therapeutics Inc	634,558	$7.729M	3.4%	$14.37	0.0%	COM	230031106
ALLO	Allogene Therapeutics Inc	3,448,275	$7.345M	3.3%	$2.47	0.0%	COM	019770106
KYMR	Kymera Therapeutics Inc	146,332	$5.887M	2.6%	$45.17	0.0%	COM	501575104
CASIF	Casi Pharmaceuticals Inc	1,329,383	$3.762M	1.7%	$4.74	0.0%	ORD SHS	G1933S101
VRDN	Viridian Therapeutics, Inc	1,974	$37,842	0.0%	$21.74	0.0%	COM	92790C104